French pharmaceuticals giant Sanofi said Wednesday that its COVID-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.
Feb 23, 2022
0
3
The European Union's drug regulator said it received an application from Novavax to authorize the American biotechnology company's coronavirus vaccine, a request that could significantly boost the continent's vaccine supplies ...
Nov 17, 2021
0
2
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
Sep 28, 2021
0
1
France's pharmaceutical giant Sanofi, which has lagged behind rivals in developing new generation mRNA Covid-19 vaccines, on Tuesday said it has purchased a US firm specialising in the technology.
Aug 3, 2021
0
142
The European Medicines Agency said Tuesday it had started a "rolling review" of France's Sanofi coronavirus jab, which could lead to authorisation for use in the European Union.
Jul 20, 2021
0
2
French pharmaceutical giant Sanofi said Tuesday that it would invest 2 billion euros ($2.4 billion) in the mRNA vaccine technology behind the pioneering Covid-19 jabs developed by rivals BioNTech-Pfizer and Moderna.
Jun 29, 2021
0
1
French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated COVID vaccine as they race to add their jab to the world's arsenal against the pandemic.
May 27, 2021
0
2
French pharmaceutical firm Sanofi on Friday announced the launch of human trials of its second COVID-19 vaccine, with its first still in the testing phase after having fallen behind in development.
Mar 12, 2021
0
2
In an unusual and potentially groundbreaking decision, French drugmaker Sanofi said Wednesday it will help bottle and package 125 million doses of the coronavirus vaccine developed by its rivals Pfizer and BioNTech, while ...
Jan 27, 2021
0
3
French pharmaceutical giant Sanofi on Thursday said it would start human trials of the potential coronavirus vaccine it is developing with British peer GSK, following promising preliminary tests.
Sep 3, 2020
0
4
